Upregulation of the peroxisome proliferator-activated receptor gamma (PPARγ) pathway could attenuate inflammation and fibrosis in hepatic tissue as well as insulin resistance, and these had been confirmed by preclinic animal research in vivo or clinic research [8, 17, 18]. This evidence concerns the gene PPARG and Insulin resistance.